Skip to main content
. 2017 Jun 20;12(6):e0178343. doi: 10.1371/journal.pone.0178343

Table 1. Characteristics of the study population.

Category boundaries Male Female P-value
N (%) - 1403 (33.52) 2782 (66.48) -
Age (yr) 40–95 63 ± 10 60 ±10 < .0001
Smoker (n, %) - 486 (34.69) 61 (2.20) < .0001
BMI (kg/m2) 13.10–27.99 23.57 ± 2.54 23.44 ± 2.53 < .0001
WC (cm) 58.00–113.00 84.75 ± 7.75 80.50 ± 8.20 < .0001
WHpR 0.67–1.33 0.91 ± 0.05 0.87 ± 0.06 < .0001
WHtR 0.34–0.73 0.51 ± 0.05 0.52 ± 0.05 < .0001
SBP (mmHg) 80–211 131 ± 19 128 ± 20 < .0001
DBP (mmHg) 38.5–127.5 77 ± 11 75 ± 10 < .0001
FBG (mmol/L) 2.49–22.25 4.79 (4.35–5.47) 4.75 (4.32–5.26) < .0001
PBG(mmol/L) 2.30–32.35 6.21 (4.99–8.20) 6.01 (4.95–7.50) 0.0003
HbA1c (%) 3.5–15.5 6.0 ± 1.2 5.8 ± 0.8 < .0001
TC (mmol/L) 0.38–14.07 4.51 ± 1.08 4.88 ± 1.10 < .0001
LDL-C (mmol/L) 0.71–9.76 3.35 ± 0.91 3.50 ± 0.97 < .0001
HDL-C (mmol/L) 0.4–2.96 1.20 ± 0.32 1.39 ± 0.33 < .0001
TG (mmol/L) 0.30–23.13 1.24 (0.89–1.86) 1.19 (0.84–1.74) 0.0012
Dyslipidemia (n, %) - 801 (57.09) 1252 (45.00) < .0001
Diabetes (n, %) - 295 (21.03) 400 (14.38) < .0001
Hypertension (n, %) - 663 (47.26) 1090 (39.19) < .0001
History of cardiovascular disease (n, %) - 62 (4.42) 88 (3.16) 0.039
Having lipid-lowering therapy (n, %) - 143 (10.19) 280 (10.06) 0.91
MS (n, %) - 416 (29.65) 856 (30.78) 0.45

Normal data were given as the mean ± SD, skewed data were given as medians (interquartile ranges) and categorical variables were given as numbers (proportions).

Abbreviations: BMI, body mass index; WC, waist circumference; WHpR, waist-to-hip ratio; WHtR, waist-to-height ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting plasma glucose; PBG, 2h post-loading plasma glucose; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; MS, metabolic syndrome.